| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 727354 | 6-[(4-FMOCamino)-1-butyl]-5,6-dihydro-2,3-dimethoxy-8,9-meth ylenedioxy-5,11-dioxo-11H-indeno[1,2-c-isoquinoline | 0.0438391811600409 | 0.16707653 |
| NSC 740975 | 6-(3-Chloropropyl)-9-cyano-5,6-dihydro-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.0438391811600409 | 0.23170375 |
| NSC 107660 | Actinomycin Pip T.beta. | 0.0438391811600412 | -0.014681511 |
| NSC 337581 | ROYLEANONE-7A-FORMYLOXY-6B-HYDROXY-ERU 701 | 0.0438391811600412 | -0.19577528 |
| NSC 606172 | Camptothecin Derivative | 0.0438391811600412 | 0.17836645 |
| NSC 682993 | Benzo[1,2-b:4,5-b']dithiophene-4,8-diol, dipropionate | 0.0438391811600418 | -0.28033058 |
| NSC 686368 | Quinazolin-4(3H)-one, 3-ethyl- 2-[[[5-(phenylamino)-1,3,4-thiadiazol-2-yl]methyl]thio]- | 0.0438391811600418 | 0.34800007 |
| NSC 690433 | Benzo[1,2-b:5,4-b']dithiophene-4,8-dione, 2,5-bis(1-hydroxyethyl)- | 0.0438391811600418 | -0.20872349 |
| NSC 102051 | Null | 0.0478540623811426 | 0.24272286 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0478540623811426 | 0.031049455 |